期刊文献+

肝总动脉闭塞后经侧支循环行TACE治疗肝癌 被引量:3

Transcatheter arterial chemoembolization for primary liver cancer through collateral arteries in patients with common hepatic arterial occlusion
原文传递
导出
摘要 目的 探讨肝总动脉(CHA)闭塞后经动脉化疗栓塞(TACE)治疗原发性肝癌(PLC)的可行性及效果.方法 回顾性分析9例PLC患者CHA闭塞后经侧支循环行TACE治疗的临床及影像学资料.结果 本研究入组1 782例PLC患者,共行4 771次TACE治疗,平均2.7次/人.9例患者出现CHA脉闭塞,发生率为0.5%(按人数计算)、0.19%(按TACE次数计算).第一、二、三、四、五、六次TACE后出现CHA闭塞者分别为1例、1例、2例、2例、2例、1例.9例发生CHA闭塞的患者平均行TACE 3.7次/人,明显高于总体的2.7次/人(P<0.05).7例CHA存在不同程度的迂曲.CHA闭塞与术中使用5F导管、CHA迂曲及TACE次数有关.9例患者均经侧支循环行TACE治疗.术后4~6周复查CT均提示碘油沉积良好,达到了有效控制肿瘤的目的.结论 对于CHA闭塞的PLC患者,经侧支循环行TACE治疗是安全、可行的,具有与CHA途径行TACE治疗同样的疗效. Objective To evaluate the feasibility and efficacy of transcatheter arterial chcmoembolizations (TACE) through collateral arteries in patients with common hepatic artery (CHA) occlusion.Methods A retrospective study was carried out on 9 patients with CHA occlusion who underwent TACE through collateral arteries.Results In 1 782 patients with primary liver cancer (PLC),4 771 TACE procedures were carried out (a mean 2.7 sessions per patient).The rate of CHA occlusion was 0.5% (9/1 782)per patient and 0.19% (9/4 771) per TACE procedure.CHA occlusion occurred after the first,second,third,fourth,fifth,sixth TACE procedure in 1,1,2,2,2,and 1 patients respectively (a mean 3.7 session per patient in these 9 patients) (P <0.05).A tortuous CHA was present in 7 patients.CHA occlusion was related to the use of a 5 F catheter,tortuous CHA,and number of TACE.All the 9 patients with occluded CHA underwent TACE through collateral arteries,and good lipiodol deposition was detected on CT scan 4-6 weeks later.Conclusion TACE carried out through collateral arteries is safe and feasible in patients with CHA occlusion.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第12期852-854,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 原发性肝癌 肝总动脉 闭塞 介入治疗 Primary liver cancer Common hepatic artery, occlusion Interventional therapy
  • 相关文献

参考文献5

二级参考文献8

共引文献33

同被引文献23

  • 1Bruix J,Sherman M;Practice Guidelines Committee,American Association for the Study of Liver Diseases.Management of hepato- cellular carcinoma[J].Hepatology,2005,42(5):1208-1236.
  • 2Nowak JZ,Jozwiak-Bebenista M,Bednarek K.Effects of PACAP and VIP on cyclic AMP formation in rat neuronal and astrocyte cul- tures under normoxic and hypoxic condition[J].Peptides,2007,28(9):1706-1712.
  • 3Borenstein X,Fiszman GL,Blidner A,et al.Functional changes in murine mammary cancer cells elicited by CoC12-induced hypoxia[J].Nitric Oxide,2010,23(3):234-241.
  • 4Takayasu K.Transarterial chemoembolization for hepatocellular carcinoma over three decades:current progress and perspective[J].Jpn J Clin Oncol,2012,42(4):247-255.
  • 5Lencioni R,Chen XP,Dagher L,et al.Treatment of intermedi- ate/ advanced hepatocellular carcinoma in the clinic:how can out- comes be improved?[J].Oncologist,2010,15(Suppl 4):42-52.
  • 6Shah RP,Brown KT,Sofocleous CT.Arterially directed therapies for hepatocellular carcinoma[J].AJR,2011,197(4):590-602.
  • 7Pouyssegur J,Dayan F,Mazure NM.Hypoxia signalling in cancer and approaches to enforce tumour regression[J].Nature,2006,441(7092):437-443.
  • 8周嘉敏,王鲁.热休克蛋白27与原发性肝癌的研究进展[J].肝脏,2012,17(4):275-277. 被引量:2
  • 9朱昱思,朱秀丽,丁晶.超声造影在原发性肝癌经导管动脉化学栓塞术疗效评价中的应用[J].上海交通大学学报(医学版),2013,33(5):694-696. 被引量:1
  • 10田慧,和振坤,徐庆杰,梁智刚.TACE联合放疗治疗原发性肝癌的疗效及对生存质量的影响[J].中国老年学杂志,2013,33(20):4987-4989. 被引量:20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部